BostonGene and Takeda Collaborate to Investigate Immunotherapies through Molecular Profiling
Shots:
- BostonGene & Takeda have partnered to conduct immuno-oncology focused research to discover key molecular drivers and predictive markers addressing treatment efficacy & adverse effects
- Takeda will conduct select early-stage clinical studies to improve trial design & indication selection plus biomarker identification for response & toxicity using BostonGene's AI-based multiomics platform
- BostonGene will utilize its computational platforms for multiomic analysis of data provided by Takeda. It will further carry out bioinformatics analysis on flow cytometry, RNA-seq & proteomics data
Ref: BostonGene | Image: BostonGene & Takeda
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
